当前位置:
X-MOL 学术
›
N. Engl. J. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-05-15 , DOI: 10.1056/nejmoa2201737 Luca Richeldi 1 , Arata Azuma 1 , Vincent Cottin 1 , Christian Hesslinger 1 , Susanne Stowasser 1 , Claudia Valenzuela 1 , Marlies S Wijsenbeek 1 , Donald F Zoz 1 , Florian Voss 1 , Toby M Maher 1 ,
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-05-15 , DOI: 10.1056/nejmoa2201737 Luca Richeldi 1 , Arata Azuma 1 , Vincent Cottin 1 , Christian Hesslinger 1 , Susanne Stowasser 1 , Claudia Valenzuela 1 , Marlies S Wijsenbeek 1 , Donald F Zoz 1 , Florian Voss 1 , Toby M Maher 1 ,
Affiliation
New England Journal of Medicine, Ahead of Print.
中文翻译:
特发性肺纤维化首选磷酸二酯酶 4B 抑制剂的试验
新英格兰医学杂志,印刷前。
更新日期:2022-05-16
中文翻译:
特发性肺纤维化首选磷酸二酯酶 4B 抑制剂的试验
新英格兰医学杂志,印刷前。